Elizabeth Comen
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 28
- Cancer Immunotherapy and Biomarkers 9
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 7
- Cancer Cells and Metastasis 7
-
- Cancer Genomics and Diagnostics 10
- Breast Cancer Treatment Studies 9
- Co-authors
- Larry Norton (25 shared papers)Tari A. King (2 shared papers)Robert Benezra (3 shared papers)Zvi Granot (1 shared paper)Erik Henke (1 shared paper)Joan Massagué (2 shared papers)Mark E. Robson (8 shared papers)Clifford A. Hudis (13 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Cancer Research (6 papers)Breast Cancer Research and Treatment (3 papers)npj Breast Cancer (3 papers)Clinical Breast Cancer (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Elizabeth Comen
45 papers receiving 2.1k citations
Elizabeth Comen's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 727
- Oncology 780
- Immunology 532
- Pathology and Forensic Medicine 129
- Pulmonary and Respiratory Medicine 203
Countries citing papers authored by Elizabeth Comen
This map shows the geographic impact of Elizabeth Comen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Comen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Comen more than expected).
Fields of papers citing papers by Elizabeth Comen
This network shows the impact of papers produced by Elizabeth Comen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Comen. The network helps show where Elizabeth Comen may publish in the future.
Co-authors
The 25 scholars most cited alongside Elizabeth Comen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung Hit paper breakdown → | 2011 | 605 |
| 2 | 2016 | 240 | |
| 3 | 2011 | 228 | |
| 4 | 2011 | 174 | |
| 5 | 2016 | 136 | |
| 6 | 2018 | 87 | |
| 7 | 2016 | 86 | |
| 8 | 2011 | 77 | |
| 9 | 2018 | 63 | |
| 10 | 2010 | 45 | |
| 11 | 2015 | 39 | |
| 12 | 2009 | 39 | |
| 13 | Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer. | 2010 | 37 |
| 14 | 2015 | 35 | |
| 15 | 2016 | 33 | |
| 16 | Tracking the seed and tending the soil: evolving concepts in metastatic breast cancer. | 2012 | 32 |
| 17 | 2013 | 29 | |
| 18 | 2012 | 27 | |
| 19 | 2004 | 20 | |
| 20 | 2016 | 20 |
About Elizabeth Comen
Elizabeth Comen is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Genetics, having authored 47 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Breast Cancer Treatment Studies (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Cells and Metastasis (7 papers), BRCA gene mutations in cancer (5 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Cancer Research (727 citations), Oncology (780 citations), Immunology (532 citations), Pathology and Forensic Medicine (129 citations) and Pulmonary and Respiratory Medicine (203 citations). Elizabeth Comen has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Larry Norton, Tari A. King, Robert Benezra, Zvi Granot, Erik Henke, Joan Massagué, Mark E. Robson, Clifford A. Hudis, George W. Sledge and Mark R. Somerfield. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment, npj Breast Cancer and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.